Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 5/20 | 0.52 |
| ▸ | CA12 | O43570 | 5/20 | 0.48 |
| ▸ | CA2 | P00918 | 2/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 3/20 | 0.38 |
| ▸ | PER2 | O15055 | 1/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.36 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.36 |
| ▸ | ABCC2 | Q92887 | 1/20 | 0.36 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.36 |
| ▸ | UGT1A7 | Q9HAW7 | 1/20 | 0.36 |
| ▸ | SLC22A11 | Q9NSA0 | 1/20 | 0.36 |
| ▸ | MMP1 | P03956 | 1/20 | 0.35 |
| ▸ | MMP2 | P08253 | 1/20 | 0.35 |
| ▸ | MMP3 | P08254 | 1/20 | 0.35 |
| ▸ | MMP8 | P22894 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8654027 | 0.95 | CA1 (0.43) | CA1CA12CA2CA14KDM4E | |
| SCHEMBL2058088 | 0.89 | CA1 (0.63) | CA1CA12CA2CA14KDM4E | |
| SCHEMBL2127290 | 0.85 | DNM1 (0.46) | CA1CA12CA2CA9 | |
| SCHEMBL12669289 | 0.85 | DNM1 (0.46) | CA1CA12CA2CA9 | |
| SCHEMBL13064494 | 0.85 | CA1 (0.40) | CA1CA12CA2CA14KDM4E | |
| Bromide SCHEMBL5769744 | 0.83 | DNM1 (0.48) | CA1CA12CA2CA9 | |
| SCHEMBL16261608 | 0.83 | CA1 (0.50) | CA1CA12CA2CA14KDM4E | |
| SCHEMBL14229365 | 0.82 | CA1 (0.55) | CA1CA12CA2CA14KDM4E | |
| SCHEMBL14229180 | 0.82 | CA1 (0.79) | CA1CA12CA2CA14KDM4E | |
| SCHEMBL18559673 | 0.82 | CA1 (0.40) | CA1CA12CA2CA14KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2850086-B1 | HETEROARYLCYANINE DYES | PACIFIC BIOSCIENCES CALIFORNIA INC (US) | 2023-07-05 | — | — | EP | disclosed |
| US-20120174324-A1 | DYES FOR POLYMER COLORATION, THEIR PREPARATION AND THEIR USE | DYSTAR COLOURS DEUTSCHLAND GMBH (DE) | 2012-07-12 | — | — | US | disclosed |
| EP-1956016-A1 | Bicyclic acyltryptophanols | Bayer Schering Pharma Aktiengesellschaft (DE) | 2008-08-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120174324-A1 | DYES FOR POLYMER COLORATION, THEIR PREPARATION AND THEIR USE | IK, H1-0, H1-5 | CA1 2765/4885CA12 1627/4885CA2 2424/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.